BioCentury
ARTICLE | Clinical News

Anagrelide CR: Updated Phase II data

June 22, 2015 7:00 AM UTC

Updated data from an open-label, U.S. Phase II trial in 18 patients with elevated platelet counts secondary to essential thrombocythemia and other myeloproliferative neoplasms showed that twice-daily ...